The role of hypertension in the pathogenesis of heart failure: A clinical mechanistic overview

Archives of Internal Medicine

Volumn 156, Issue 16, 1996, Pages 1789-1793

  Vasan, Ramachandran S ^a,c   Levy, Daniel ^a,b,c,d  

^a FRAMINGHAM HEART STUDY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0029793195     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.16.1789     Document Type: Review

References (159)

1. Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol. 1993;22(suppl A):3A-5A.
2. Gillum RF. Epidemiology of heart failure in the United States. Am Heart J. 1993;126:1042-1047.
3. Centers for Disease Control and Prevention. Mortality from congestive heart failure - United States, 1980-1990. MMWR Morb Mortal Wkly Rep. 1994;43:77-81.
4. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107-115.
5. Anderson GM, Newhouse JP, Ross LL. Hospital care for elderly patients with diseases of the circulatory system. N Engl J Med. 1989;321: 1443-1448.
6. Gooding J, Jette AM. Hospital readmissions among the elderly. J Am Geriatr Soc. 1985;33: 595-601.
7. Parmley WW. Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol. 1989;13:721-785.
8. Smith WM. Epidemiology of congestive heart failure. Am J Cardiol. 1985;55(suppl 1):3-8.
9. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Heart Study. N Engl J Med. 1971;285:1441-1446.
10. Erikson H, Svärdsudd K, Larsson B, et al. Risk factors for heart failure in the general population: The Study of Men Born in 1913. Eur Heart J. 1989;10:647-656.
11. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Heart Study. J Am Coll Cardiol. 1993;32 (suppl A):6A-13A.
12. Johnstone D, Limacher M, Rousseau M, et al. Clinical characteristics of patients in Studies of Left Ventricular Dysfunction (SOLVD). Am J Cardiol. 1992;70:894-900.
13. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure: the Studies of Left Ventricular Dysfunction (SOLVD) investigators. J Am Coll Cardiol. 1993;22(suppl A):14A-19A.
14. Alexander M, Grumbach K, Selby J, Brown AF, Washington E. Hospitalization for congestive heart failure: explaining the racial differences. JAMA. 1995;274:1037-1042.
15. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J. 1991;121:1852-1853.
16. LeJemtel TH, Sonnenblick EH. Heart failure: adaptive and maladaptive processes. Circulation. 1993; 87(suppl VII):VII-1-VII-4.
17. Yusuf S, Abbott RA. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension. 1989; 13(suppl I):I-74-I-79.
18. Veterans Administrative Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA. 1967;202: 1028-1034.
19. Veterans Administrative Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. JAMA. 1970; 213:1143-1151.
20. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.
21. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekborn T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients With Hypertension (STOP-Hypertension). Lancet. 1991; 338:1281-1285.
22. Cutler JA, Psaty BM, MacMahon S, Furberg C. Public health issues in hypertension control: what has been learned from clinical trials. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Treatment. New York, NY: Raven Press; 1995:253-270.
23. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960-1991. Hypertension. 1995;26: 60-69.
24. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence and mortality in the Framingham Study. Ann Intern Med. 1969;71: 89-105.
25. Prineas RJ, Castle CH, Curb JD, Harrist R, Lewin A, Stamler J. Hypertension Detection and Follow-up Program: baseline electrocardiographic characteristics of the hypertensive participants. Hypertension. 1983;5:160-189.
26. Levy D. Left ventricular hypertrophy: epidemiologic insights from the Framingham Heart Study. Drugs. 1988;35(suppl 5):1-5.
27. Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol. 1987;60 (suppl I):85I-93I.
28. Liebson PR, Grandits G, Prineas R, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1993;87:476-486.
29. Lee DK, Marantz PR, Devereux RB, et al. Left ventricular hypertrophy in blacks versus white hypertensives: standard electrocardiographic criteria overestimate differences in prevalence. JAMA. 1992;267:3291-3299.
30. Hypertension Detection and Follow-up Cooperative Group. Five year findings of the Hypertension Detection and Follow-up Program: reduction of mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242:2562-2571.
31. Devereux RB, Casale PN, Eisenberg RR, et al. Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard: comparison of standard criteria, computer diagnosis and physician interpretation. J Am Coll Cardiol. 1984;3:82-87.
32. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: The Framingham Heart Study. Ann Intern Med. 1988;108:7-13.
33. Hammond IW, Devereux RB, Alderman MH, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 1986; 7:639-650.
34. Savage DD, Drayer JIM, Henry WL, et al. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation. 1979;59:623-632.
35. Devereux RB, Casale PN, Hammond IW, et al. Echocardiographic detection of pressure-overload hypertrophy: effect of criteria and patient population. J Clin Hypertens. 1987;3:66-78.
36. Urbina EM, Sidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation. 1995;91: 2400-2406
37. Schieken RM, Clarke WR, Lauer RM. Left ventricular hypertrophy in children with blood pressures in the upper quintile of the distribution: the Muscatine Study. Hypertension. 1981;3: 669-675.
38. Gardin JM, Wagenknecht LE, Anton-Culver H, et al. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women (The CARDIA Study). Circulation. 1995; 92:380-387.
39. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: The Framingham Heart Study. J Am Coll Cardiol. 1991;18:1287-1296.
40. Kleinert HD, Harshfield GA, Pickering TG, et al. What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension. 1984;6:574-578.
41. Devereux RB, Pickering TG. Relationship between ambulatory and exercise blood pressure and cardiac strucure. Am Heart J. 1988; 116:1124-1133.
42. Devereux RB. Pickering TG, Harshfield GA, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure responses to regularly recurring stress. Circulation. 1983;68:470-476.
43. Ren J-F, Hakki A-H, Kotler MN, Iskandrian A. Exercise systolic blood pressure: a powerful determinant of increased left ventricular mass in patients with hypertension. J Am Coll Cardiol. 1985;5:1224-1231.
44. Savage DD. Levy D, Dannenberg AL, Garrison RJ, Castelli WP. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). Am J Cardiol. 1990;65:371-376.
45. Shub C, Klein A, Zachariah PK, Bailey KR, Tajik AJ. Determinants of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size. Mayo Clin Proc. 1994;69:205-211.
46. Gardin JM, Siscovick D, Anton-Culver H, et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly: The Cardiovascular Health Study. Circulation. 1995;91:1739-1748.
47. Lauer MS, Anderson KM, Levy D. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol. 1992;19:130-134.
48. De Simone G, Devereux RB, Roman MJ, Alderman MH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994;23:600-606.
49. Galderisi M, Anderson KM, Wilson PWF, Levy D. Echocardiographic evidence for the existence of a distinct cardiomyopathy (The Framingham Heart Study). Am J Cardiol. 1991;68:85-89.
50. Dunn FG, Oigman W, Sungaard-Riise K, et al. Racial differences in adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol. 1983;1:1348-1351.
51. Koren MJ, Mensah GA, Blake J, Laragh JH, Devereux RB. Comparison of left ventricular mass and geometry in black and white patients with essential hypertension. Am J Hypertens. 1993; 6:815-823.
52. Savage DO, Henry WL, Mitchell JR, et al. Echocardiographic comparison of black and white hypertensive subjects. J Natl Med Assoc. 1979; 71:709-712.
53. Chaturvedi N, Athanassopoulos G, McKeigue PM, Marmot M, Nihoyannopoulos P. Echocardiographic measures of left ventricular structure and their relation with rest and ambulatory blood pressure in blacks and whites in the United Kingdom. J Am Coll Cardiol. 1994;24:1499-1505.
54. Gottdiener JS, Reda DJ, Materson BJ, et al. Importance of obesity, race and age to cardiac structural and functional effects of hypertension. J Am Coll Cardiol. 1994;24:1492-1498.
55. Harshfield GA, Grim CE, Hwang C, Savage DD, Anderson SJ. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens. 1990;3:538-543.
56. Iwai N, Nakamura V, Kinoshita M. DD genotype of the angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994;90:2622-2628.
57. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550-1558.
58. de Simone G, Devereux RB, Roman MJ, Schlussel Y, Alderman MH, Laragh JH. Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension. Ann Intern Med. 1991;114:202-209.
59. Post WS, Larson MG, Levy D. Impact of left ventricular structure on the incidence of hypertension. Circulation. 1994;90:179-185.
60. Iso H, Kiyama M, Doi M, et al. Left ventricular mass and subsequent blood pressure changes in rural and urban Japanese populations. Circulation. 1994;89:1717-1724.
61. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med. 1993;153:598-615.
62. Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis. 1978;31:201-306.
63. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1 : prolonged differences in blood pressure corrected for the regression dilution bias. Lancet. 1990;335:765-774.
64. Kannel WB, Wolf PA, Garrison RJ, eds. Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death in Pooled Repeated Biennial Measurements: Framingham Heart Study, 30 Year Follow-up. Bethesda, Md: National Institutes of Health; 1987:section 34. Publication NIH 87-2703.
65. Rosenman RH, Sholtz RI, Brand RJ. A study of comparative blood pressure measures in predicting risk of coronary heart disease. Circulation. 1976;54:51-58.
66. Rabkin SW, Mathewson FAL, Täte RB. Longitudinal blood pressure measures in predicting risk of coronary heart disease. Am J Epidemiol. 1979;109:650-662.
67. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
68. Sagie A, Larson MG, Levy D. The natural history of borderline isolated sytolic hypertension. N Engl J Med. 1993;329:1912-1917.
69. Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. Fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993; 153:154-183.
70. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation. 1991; 83:356-362.
71. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316 099 white men. Arch Intern Med. 1992;152:56-64.
72. Samuelson O, Wilhelmsen L, Andersson OK, Pennent K, Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. JAMA. 1987;258:1768-1776.
73. Rabkin SW, Mathewson FAL, Täte RB. Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol. 1977;40:604-610.
74. Herlitz J, Karlson BW, Richter A, Wiklund O, Jablonskiene D, Hjalmarson A. Prognosis in hypertensives with acute myocardial infarction. J Hypertens. 1992;10:1265-1271.
75. Kannel WB, Sorlie P, Castelli WP, McGee D. Blood pressure and survival after myocardial infarction: The Framingham Heart Study. Am J Cardol. 1980;45:326-330.
76. Berger CJ, Murabito J, Evans JC, Anderson KM, Levy D. Prognosis after first myocardial infarction: comparison of Q wave and non-Q wave myocardial infarction in the Framingham Heart Study. JAMA. 1992;268:1545-1551.
77. Volpi A, Vita CD, Franzosi MG, et al. Determinants of 6 month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation. 1993;88: 416-429.
78. Wong ND, Cupples LA, Ostfeld AM, Levy D, Kannel WB. Risk factors for long-term coronary prognosis alter initial myocardial infarction: The Framingham Heart Study. Am J Epidemiol. 1989; 130:469-480.
79. Borhani N, Blaufox D, Oberman A, Polk BF. Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis. 1986;29:55-62.
80. The Coronary Drug Project Research Group. Left ventricular hypertrophy pattern and prognosis: experience post infarction in the Coronary Drug Project. Circulation. 1974;49:862-869.
81. Wong ND, Levy D, Kannel WB. Prognostic significance of the electrocardiogram after Q wave myocardial infarction. Circulation. 1990;81:780-789.
82. Behar S, Reicher-Reiss H, Abinader E, et al. Long term prognosis after myocardial infarction in patients with left ventricular hypertrophy on the electrocardiogram. Am J Cardiol. 1992;69:985-990.
83. Boden WE, Kleiger RE, Schechtman KB, Capone RJ, Schwartz DT, Gibson RS, and the Diltiazem Reinfarction Study Group. Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction. Am J Cardiol. 1988;62: 1000-1004.
84. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in The Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
85. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105:173-178.
86. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh J. Relation of left ventricular mass and geometry to morbidity and mortality in men and women with essential hypertension. Ann Intern Med. 1991;114:345-352.
87. Mensah GA, Pappas TW, Koren MJ, Ulin RJ, Laragh JH, Devereux RB. Comparison of classification of hypertension severity by blood pressure level and World Health Organization criteria for prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension. J Hypertens. 1993;11: 1429-1440.
88. Krumholz H, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995;25: 879-884.
89. Galderisi M, Lauer M, Levy D. Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study). Am J Cardiol. 1992; 70:971-976.
90. Bolognese L, Dellavesa P, Rossi L, Sarasso G, Bongo AS, Scianaro M. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol. 1994;73:1-5.
91. Liao Y, Cooper RS, McGee DL, Mensah GA, Ghali JK. The relative effects of left ventricular hypertrophy, coronary artery disease, and left ventricular dysfunction on survival among black patients. JAMA. 1995;273:1592-1597.
92. Devereux RB, Roman MJ. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease. J Hypertens. 1993;11(suppl 4):S3-S9.
93. Inouye I, Massie B, Loge D, et al. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol. 1985;53:120-126.
94. Smith VE, Schulman P, Karimeddini MK, et al. Rapid ventricular filling in left ventricular hypertrophy, II: pathologic hypertrophy. J Am Coll Cardiol. 1985;5:869-874.
95. Pearson AC, Gudipati C, Nagelhout D, Sear J, Cohen JD, Labovitz AJ. Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension. J Am Coll Cardiol. 1991;17:422-30.
96. Sagie A, Benjamin EJ, Galderisi M, et al. Echocardiographic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (The Framingham Heart Study). Am J Cardiol. 1993;72:662-665.
97. Fouad F, Slominiski M, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol. 1984;3:1500-1506.
98. Snider AR, Gidding AS, Rocchini AP, et al. Doppler evaluation of left ventricular diastolic filling in children with systemic hypertension. Am J Cardiol 1985;56:921-926.
99. Devereux RB. Left ventricular diastolic dysfunction: early diastolic relaxation and late diastolic compliance. J Am Coll Cardiol. 1989;13: 337-339.
100. Bonaduce D, Breglio R, Conforti G, et al. Myocardial hypertrophy and left ventricular diastolic function in hypertensive patients: an echo Doppler evaluation, Eur Heart J. 1989;10:611-621.
101. Ren J, Pancholi SB, Iskandrian AS, et al. Doppler echocardiographic evaluation of the spectrum of left ventricular diastolic dysfunction in essential hypertension. Am Heart J. 1994;127: 906-913.
102. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988;62:757-765.
103. Hess OM, Schneider J, Koch R, Bamert C, Grimm J, Krayenbuehl HP. Diastolic function and myocardial structure in patients with myocardial hypertrophy. Circulation. 1981;63:360-371.
104. Grossman W, McLaurin LP, Stefadourous MA. Left ventricular stiffness associated with chronic pressure and volume overloads in man. Circ Res. 1974;35:793-800.
105. Barbier P, Alioto GA, Guazzi MD. Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1994;24:165-170.
106. Benjamin EB, Levy D, Vaziri S, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA. 1994;271:840-844.
107. Shah PM, Pai RG. Diastolic heart failure. Curr Probl Cardiol, 1992;17:783-868.
108. Devereux RB, Savage DD, Drayer JIM, Laragh JH. Left ventricular hypertrophy and function in high, normal and low renin forms of hypertension. Hypertension. 1982;4:524-531.
109. Frohlich ED, Tarazi RC, Dustan HP. Clinicalphysiological correlations in the development of hypertensive heart disease. Circulation. 1971; 44:446-455.
110. Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy. Circulation. 1991;83: 1676-1684.
111. De Simone G, Devereux RB, Roman MJ, et al. Assessment of left ventricular function by mid-wall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol. 1994;23:1444-1451.
112. Wasserman AG, Katz RJ, Varghese PJ, et al. Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain. N Engl J Med. 1984;311:1276-1280.
113. Blake J, Devereux RB, Borer JS, Szulc M, Pappas TW, Laragh JH. Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. Am J Med. 1990; 88:477-485.
114. Sobue T, Yokoto M, Iwase M, Ishihara H. Influence of left ventricular hypertrophy on left ventricular function during dynamic exercise in the presence or absence of coronary artery disease. J Am Coll Cardiol. 1995;25:91-98.
115. Cuocolo A, Sax FL, Brush JE, et al. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension: diastolic mechanisms for systolic dysfunction during exercise. Circulation. 1990;81:978-86.
116. Johnson RA, O'Gara PT, Jacobs ML, Daggett Jr WM. Heart failure resulting from coronary artery disease. In: Eagle KA, Haber E, DeSanctis RW, Austin WG, eds. The Practice of Cardiology. 2nd ed. Boston, Mass: Little Brown & Co; 1989:455-493.
117. Simoons ML, Vos J, Tijssen JGP, et al. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands. J Am Coll Cardiol. 1989;14:1609-1615.
118. Guerci AD, Gerstenblith G, Brinker JA, et al. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med. 1987;317: 1613-1618.
119. Pfeffer MA, Braunwald E. Ventricular remodelling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
120. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87:755-763.
121. Nolan SE, Mannisi JA, Bush DE, Healy B, Weismann HF. Increased atterload aggravates infarct expansion after acute myocardial infarction. J Am Coll Cardiol. 1938;12:1318-1325.
122. Nishikimi T, Yamagishi H, Takeuchi K, Takeda T. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat. Cardiovasc Res. 1995;29:856-861.
123. Dodek A, Kassebaum DG, Bristow JD. Pulmonary edema without cardiomegaly: ischemic cardiomyopathy and the small stiff heart. Am Heart J. 1972;85:281-284.
124. Forrester JS, Diamond G, Parmley W, Swan HJC. Early increase in left ventricular compliance after myocardial infarction. J Clin Invest. 1972; 51:598-603.
125. Johannessen KA, Cerqueira MD, Stratton JR. Influence of myocardial infarction size on radionuclide and Doppler echocardiographic measurements of diastolic function. Am J Cardiol. 1990;65:692-697.
126. Pipilis A, Meyer TE, Ormerod O, Flather M, Sleight P. Early and late changes in left ventricular filling after acute myocardial infarction and the effect of infarct size. Am J Cardiol. 1992;70:1397-1401.
127. Nishimura RA, Housmans PR, Hatle LK, Tajik AJ. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography, part II: clinical studies. Mayo Clin Proc. 1989;64:181-204.
128. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling following myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74:693-702.
129. Mirsky I, Cohn PF, Levine JA, et al. Assessment of left ventricular stiffness in primary myocardial disease and coronary artery disease. Circulation. 1974;50:128-36.
130. Pouleur H, Rousseau MF, van Eyll C, Melin J, Youngblood M, Yusuf S. Cardiac mechanics during development of heart failure. Circulation. 1993;87(suppl IV):IV-14-IV-20.
131. Kannel WB, Sorlie P, McNamara PM. Prognosis after initial myocardial infarction: the Framingham Heart Study. Am J Cardiol. 1979;44:53-59.
132. Dwyer EM, McMaster P, Greenberg H, and the Multicenter Postinfarction Research Group. Non-fatal cardiac events and recurrent infarction in the year after myocardial infarction. J Am Coll Cardiol. 1984;4:695-702.
133. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, II: morbidity results. JAMA. 1983;250:2814-2819.
134. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazern on mortality and reinfarction after myocardial infarction. N Engl J Med. 1988;319:385-392.
135. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results ol the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med. 1992;327:678-684.
136. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since the introduction of thrombolysis. BMJ. 1993;307: 349-353.
137. Lichstein E, Hager WD, Gregory JJ, Fleiss JL, Rolnitzky LM, Bigger JT, for the Multicenter Diltiazem Post-Infarction Research Group. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and chances of developing congestive heart failure. J Am Coll Cardiol. 1990;16:1327-1332.
138. Pfeffer MA, Braunwald E, Moye LA, et al, on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327: 669-677.
139. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 1992; 327:685-691.
140. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
141. Lamas GA, Vaughan DE, Parisi AF, Pfeffer MA. Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol. 1989; 63:1167-1173.
142. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol. 1989;137:1637-1652.
143. Port JD, Gilbert EM, Larrabee P, et al. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. Circulation. 1990;81:929-938.
144. Konstam MA, Kronenberg MW, Udelson JE, et al. Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction. Am J Cardiol. 1992; 69:1591-1595.
145. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation. 1990; 82:1724-1729.
146. Minotti JR, Pillay P, Change L, Wells L, Massie BM. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation. 1992;86:903-908.
147. Echeverria HH, Bilsker HS, Myerburg RJ, Kessler KM. Congestive heart failure: echocardiographic insights. Am J Med. 1983;75:750-755.
148. Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol. 1984; 54:778-782.
149. Soufer R, Wohlgelernter D, Vita NA, et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol. 1985; 55:1032-1036.
150. Cohn JN, Johnson G, and Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction: the V-HEFT Study. Circulation. 1990:81(suppl III):III-48-III-53.
151. Franz IW, Ketelhut R, Behr U, Tonnesmann U. Time course of reduction in left ventricular mass during long-term antihypertensive therapy. J Hum Hypertens. 1994;8:191-198.
152. Lamas GA. Left ventricular hypertrophy in post-myocardial infarction left ventricular remodeling and in hypertension: similarities and contrasts. Eur Heart J. 1993;14(suppl J):15-21.
153. Ito H, Yu H, Tomooka T, et al. Incidence and time course of left ventricular dilation in the early convalescence stage of reperfused anterior wall acute myocardial infarction. Am J Cardiol. 1994; 73:539-543.
154. Kleber FX, Niemöller L, Fischer M, Doering W. Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition. Am J Cardiol. 1991;68(suppl D):121D-126D.
155. Kannel WB. Epidemiological aspects of heart failure. Cardiol Clin. 1989;7:1-9.
156. Rodeheffer RJ, Jacobsen SJ, Gersh BJ, et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clinic Proc. 1993;68:1143-1150.
157. Andersson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J. 1993;126: 632-640.
158. Hebert P, Moser M, Mayer J, Hennekens C. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993; 153:578-581.
159. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996;27:1214-1218.